Skip to main content
Top
Published in: European Journal of Medical Research 1/2021

Open Access 01-12-2021 | Cardiomyopathy | Case report

Multiorgan failure with fatal outcome after stem cell tourism

Authors: Željka Večerić-Haler, Špela Borštnar, Boštjan Luzar, Maja Jerše, Nika Kojc

Published in: European Journal of Medical Research | Issue 1/2021

Login to get access

Abstract

Background

Unproven stem cell treatments may involve serious health, personal, and financial considerations. Due to worldwide spread, illegal stem cell therapies have become a major public health problem. We have already witnessed numerous reports in the mass media of severe and occasionally even fatal outcomes after such therapies. However, there are only few scientifically documented cases in which the causality between stem cell therapy and side effects cannot be refuted.

Case presentation

Here we present a case report of a 48-year-old patient with serious side effects, including disseminated skin ulcers, hepatitis, and cardiomyopathy, with eventual fatal outcome following unproven stem cell treatment.

Conclusions

The case of the patient presented here draws attention to the worst possible outcome of stem cell tourism. To effectively combat this issue, professionals and patients should be empowered with the right knowledge on possible side effects.
Appendix
Available only for authorised users
Literature
1.
go back to reference Matthews KR, Iltis AS. Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders. BMC Med Ethics. 2015;16(1):75.CrossRef Matthews KR, Iltis AS. Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders. BMC Med Ethics. 2015;16(1):75.CrossRef
2.
go back to reference Bauer G, Elsallab M, Abou-El-Enein M. Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions. Stem Cells Transl Med. 2018;7(9):676–85.CrossRef Bauer G, Elsallab M, Abou-El-Enein M. Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions. Stem Cells Transl Med. 2018;7(9):676–85.CrossRef
3.
go back to reference Chalasani NP, et al. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950–66.CrossRef Chalasani NP, et al. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950–66.CrossRef
4.
go back to reference Hoofnagle JH, Bjornsson ES. Drug-induced liver injury—types and phenotypes. N Engl J Med. 2019;381(3):264–73.CrossRef Hoofnagle JH, Bjornsson ES. Drug-induced liver injury—types and phenotypes. N Engl J Med. 2019;381(3):264–73.CrossRef
5.
go back to reference Chung WH, Wang CW, Dao RL. Severe cutaneous adverse drug reactions. J Dermatol. 2016;43(7):758–66.CrossRef Chung WH, Wang CW, Dao RL. Severe cutaneous adverse drug reactions. J Dermatol. 2016;43(7):758–66.CrossRef
6.
go back to reference Penack O, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020;7(2):e157–67.CrossRef Penack O, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020;7(2):e157–67.CrossRef
7.
go back to reference Matsukuma KE, et al. Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD). J Gastrointest Oncol. 2016;7(Suppl 1):S21-31.PubMedPubMedCentral Matsukuma KE, et al. Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD). J Gastrointest Oncol. 2016;7(Suppl 1):S21-31.PubMedPubMedCentral
8.
go back to reference Strong Rodrigues K, et al. Cutaneous graft-versus-host disease: diagnosis and treatment. Am J Clin Dermatol. 2018;19(1):33–50.CrossRef Strong Rodrigues K, et al. Cutaneous graft-versus-host disease: diagnosis and treatment. Am J Clin Dermatol. 2018;19(1):33–50.CrossRef
9.
go back to reference Hineno A, et al. Calciphylaxis as a catastrophic complication in a patient with POEMS syndrome. Case Rep Neurol. 2009;1(1):47–53.CrossRef Hineno A, et al. Calciphylaxis as a catastrophic complication in a patient with POEMS syndrome. Case Rep Neurol. 2009;1(1):47–53.CrossRef
10.
go back to reference Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018;379(4):399–400.PubMed Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018;379(4):399–400.PubMed
11.
go back to reference Nigwekar SU, et al. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008;3(4):1139–43.CrossRef Nigwekar SU, et al. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008;3(4):1139–43.CrossRef
12.
go back to reference Sammour YM, et al. Non-uremic calciphylaxis associated with alcoholic hepatitis: a case report. World J Hepatol. 2019;11(1):127–32.CrossRef Sammour YM, et al. Non-uremic calciphylaxis associated with alcoholic hepatitis: a case report. World J Hepatol. 2019;11(1):127–32.CrossRef
Metadata
Title
Multiorgan failure with fatal outcome after stem cell tourism
Authors
Željka Večerić-Haler
Špela Borštnar
Boštjan Luzar
Maja Jerše
Nika Kojc
Publication date
01-12-2021
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2021
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-020-00477-4

Other articles of this Issue 1/2021

European Journal of Medical Research 1/2021 Go to the issue